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Abstract: The research in our laboratory focuses on the role of metal ions and their complexes in structure for-
mation and folding of nucleic acids. Large catalytic RNAs, like group II introns and some riboswitches, as well 
as shorter RNAs and DNAs containing modified nucleotides  for  the assembly of nanodevices are examined. 
Abundant metal ions like Mg2+ or natural metabolites like coenzyme B12 are in the center of interest, but also other 
metal ions, complexes thereof and B12 derivatives are applied with the aim to understand the largely unknown 
and manifold non-covalent interactions with nucleic acids. We apply a multitude of techniques, including poten-
tiometric pH titrations, NMR spectroscopy, X-ray crystallography, gel electrophoresis and single molecule FRET 
experiments. Here we briefly summarize each of our research topics emphasizing the interaction of coenzyme 
B12 and its derivatives with the btuB riboswitch of E. coli. This highly conserved sequence, found in the 5’-un-
translated region (5’-UTR) of the btuB mRNA, is involved in the regulation of the btuB protein expression. After a 
summary on the historical discovery of such riboswitches and their mechanism of action, we shortly focus on our 
own contributions to understand the structural equilibrium, high affinity and selectivity of the interaction between 
this specific RNA sequence and the largest and most complex cellular metabolite, coenzyme B12. 
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1. Introduction
Since the discovery of catalytically 
active RNA sequences, named ribozymes 
from here on, by the Cech and Altman lab-
oratories in the early 1980s,[1,2] the knowl-
edge on functional RNAs, being either 
synthetic or natural, has steadily increased. 
Today it is known that RNA is involved in a 
multitude of cellular processes, sometimes 
also performing catalytic functions. RNA 
molecules can thereby act either indepen-
dently of any protein cofactor or as RNA–
protein complexes, e.g. the ribosome 
(protein biosynthesis) or the spliceosome 
(mRNA splicing in eukaryotic cells).[3] 
Independent of the nucleic acids’ size 
and function, metal ions are the most cru-
cial and abundant cofactors, determining 
folding, global, and local structures, as 
well as taking directly part in catalysis of 
ribozymes.[4] Mg2+ and K+ are usually con-
sidered the naturally involved metal ions 
with nucleic acids in the cell.[5] However, 
also other metal ions are available and 
might take part in folding and catalysis.[5–8] 
In all cases it is unknown so-far how metal 
ions exactly influence the structure and ac-
tivity on the atomic level. To answer this 
fundamental question is the driving force 
of our research.
2. Metal ions in the Catalytic Center 
of Group II Intron Ribozymes
Group II introns are natural self-splic-
ing catalytic RNAs and are among the 
largest ribozymes known.[9] They occur in 
some bacteria, but mainly in plants, fungi, 
and lower eukaryotes. These macromol-
ecules are closely related to the eukaryotic 
splicing machinery and are considered the 
ancestors of up to about 40% of the hu-
man genome.[10] Group II introns catalyze 
a diverse set of reactions like splicing but 
also reinsertion into DNA, being mobile 
genetic elements. The nature of the metal 
ion present in solution has thereby a strong 
influence on the catalytic activity of these 
ribozymes.[8,11–13] Recently, a first X-ray 
structure of a self-splicing group II intron 
has been solved, although unfortunately at 
too low resolution to learn much about the 
metal ions present.[14]
We aim to determine the specific metal 
ion binding sites within the active struc-
ture and characterize their thermodynamic 
properties. By means of NMR, we deter-
mine the solution structures of domains 
and subdomains which are part of the 
catalytic core and subsequently charac-
terize their metal ion binding properties 
by various spectroscopic techniques (Fig. 
1).[15–22] One of the biggest challenges is 
the determination of the metal ion affinities 
because usually several metal ions simul-
taneously bind to one RNA molecule with 
similar affinities. We have thus developed 
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an iterative approach to calculate the in-
trinsic binding constants of different metal 
ions to one ligand, e.g. a RNA hairpin, 
based on NMR titration experiments.[17] 
Further NMR experiments are conducted 
to identify the specific liganding atoms of 
the RNA:[18] The main problem hereby lies 
in the fact that each of the four nucleotide 
building blocks offers a multitude of po-
tential coordination sites, e.g. the phos-
phate oxygens or the N(7) of the purines. 
At the same time inner-sphere, i.e. direct 
coordination, or outer-sphere binding, me-
diated through a water molecule, can take 
place, further complicating the situation. 
Nevertheless, a surprising selectivity and 
specificity of RNAs for given metal ions is 
reached,[8] which we aim to reveal on the 
coordination chemical level (for a recent 
review, see ref. [21]). Only in this way will 
we finally be able to understand the ribo-
zyme mechanism and modify these mol-
ecules for further needs.
3. From Mn+ Binding to Nucleotides 
to Nucleic Acids
Metal ion coordination to mononucle-
otides is relatively well understood.[24–26] 
In the past years, we have extended these 
studies towards phosphorothioate deriva-
tives,[27,28] dinucleotides,[29–31] as well as 
the binding of two metal ions to one nu-
cleobase.[32] Surprisingly, in the latter case, 
the binding of the second metal ion is only 
slightly hampered by the presence of the 
first one.[32] We have now used this accu-
mulated wealth of information to create a 
library of stability increments for the indi-
vidual liganding atoms towards Mg2+, Ca2+, 
Mn2+, Cu2+, Zn2+, Cd2+ or Pb2+.[33] These 
increments can be applied to estimate the 
intrinsic affinities of nucleic acid-binding 
pockets for the mentioned metal ions and 
thus to provide first insights into the ther-
modynamics of individual binding pockets 
within large nucleic acid structures. 
To assist the above-mentioned ap-
proach of adding up stability increments 
and to allow for a rigorous examination of 
all known metal ion binding pockets, we 
have built up a freely available database 
on Metal Ions in Nucleic AcidS (MINAS) 
(Fig. 2).[34] This database can be used to 
evaluate, visualize, and characterize the 
metal ion binding sites of all structures de-
posited in the PDB and NDB.
4. Metal Ion-assisted Folding of 
Large RNAs
Metal ions induce and direct the fold-
ing of RNAs.[35,36] In most cases, the pres-
ence of divalent metal ions leads to a rapid 
collapse into different kinetic traps and to 
a subsequent slow three-dimensional rear-
rangement of the (sub)domains into the 
active structure.[37,38] Group II introns be-
have differently: A first slow folding step 
is followed by a series of fast consecutive 
steps obeying a straight pathway devoid 
of kinetic traps.[39–41] We have recently 
characterized the folding pathway of one 
of these large RNAs by single molecule 
Fluorescence Resonance Energy Transfer 
Fig. 1. Group II intron ribozymes. (A) Schematic splicing reaction, i.e. the removal of the intronic 
sequence and joining of the two flanking exons. Both steps are reversible and performed without 
the aid of proteins. (B) Schematic secondary structure of the yeast mitochondrial group II intron 
Sc.ai5g. Regions that are part of the catalytic core and in the focus of our research are colored 
and metal ion binding sites indicated as magenta spheres. NMR solution structures of the intron-
exon interaction, domains 5 and 6, as solved in our lab, are shown to the right, based on the 
PDB files 2K64,[20] 1R2P,[15] and 2AHT[16] and prepared with MOLMOL.[23] Domain 5 is the most 
conserved region of the intron and domain 6 contains the nucleophile in the first step of splicing.
Fig. 2. Database of 
Metal Ions in Nucleic 
AcidS (MINAS; www.
minas.uzh.ch). This 
database contains all 
metal ion-nucleic acid 
structures of the PDB 
and NDB and allows a 
detailed analysis of the 
metal ion coordination 
spheres.
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in our laboratory, the aim is to construct 
nanodevices with particular electric, mag-
netic and sensing properties.[47,48] 
6. Sensing Metal Ion Metabolites 
by RNA
Riboswitches are recently discovered 
highly conserved sequences in the untrans-
lated regions (UTR) of mostly bacterial 
mRNAs. Upon binding to certain metabo-
lites with high specificity and selectivity 
these RNAs change their three-dimension-
al structure thus regulating gene expres-
sion and metabolite concentration on the 
translational or transcriptional level.[49] 
Our research focuses on the Mg2+- and 
coenzyme B12-sensitive riboswitches[50,51] 
whereby the latter is explained in more de-
tail in the following Section.
7. Riboswitches
Riboswitches are conserved sequences 
within mRNA guiding very elegantly pro-
tein-independent gene-regulation.[49,51–54] 
Out of the more than 20 riboswitch classes 
discovered so far, only the TPP-binding 
riboswitch is known to be present also in 
archeae, fungi and plants,[55–58] whereas 
all others are restricted to bacteria where 
they are believed to regulate up to 2% of 
the genes.[59] Due to their overwhelming 
occurrence in bacteria, riboswitches are of 
increasing interest as new targets for the 
design of antimicrobial drugs.[60]
Riboswitches act as natural aptamers 
that bind to small metabolites with very 
high affinity. Such metabolites are ami-
no acids, purine bases, redox cofactors, 
metal ions, second messengers and oth-
ers. It is highly intriguing how RNA com-
posed of only four building blocks is able 
to recognize and bind such a variety of 
ligands different in size, charge and func-
tional groups. As it turns out, hydrogen-
bonding, electrostatic and van der Waals 
interactions as well as Watson-Crick base 
pairing and stacking interactions are used 
concomitantly to ensure specificity and 
affinity.[56,61–63]
Riboswitches generally consist of a 
highly conserved aptamer domain, a re-
gion of 35 to 260 nucleotides, which rep-
resents the metabolite binding part, and a 
downstream expression platform. Metabo-
lite binding causes considerable conforma-
tional changes in secondary and tertiary 
structure and subsequent reorganization 
of the expression platform, the latter be-
ing finally responsible for gene regulation. 
The downstream genes all have a close 
physiological relationship with the bound 
metabolite, i.e. they encode for transport 
proteins or proteins involved in the biosyn-
(smFRET) spectroscopy[42] and investigat-
ed the effect of Ca2+ on this folding path-
way (Fig. 3):[43] Already small amounts of 
Ca2+ affect the global structure of this ~700 
nucleotide long RNA. Unprecedentedly, 
two distinct subpopulations were observed 
that do not interchange with each other. 
It was highly surprising to see the single 
molecules fold into two distinctly different 
three-dimensional structures occurring in 
parallel under the same conditions.[43] 
5. From Nature to Nano-devices
Metal ions usually bind to the major and 
minor groove edges of nucleotides within 
duplex or complex nucleic acids as they 
occur manifold in nature. Our interests lie 
in the investigation of structures contain-
ing metal ions in the center of the nucleic 
acid duplex. For example, Hg2+ ions can 
be ‘trapped’ in the helix center between 
two opposite thymine or uracil nucleo-
bases, which become deprotonated upon 
coordinating the metal ion at N(3).[44,45] 
Recently we succeeded in determining 
the first three-dimensional structure of a 
metallated DNA duplex containing artifi-
cial imidazole nucleotides with three lin-
early coordinated Ag+ ions aligned in the 
middle (Fig. 4).[46] Based on solution struc-
tures and investigations on the metal ion-
initiated structural changes as performed 
Fig. 3. Single molecule 
FRET studies of group 
II intron folding. (A) 
Schematic setup of 
smFRET experiments: 
The RNA molecules are 
attached via a biotin/
streptavidin interaction 
to a quartz slide, the 
donor fluorophore 
excited by a laser, 
and the fluorescence 
measured by a CCD 
camera from below. 
(B) Folding pathway 
of a Sc.ai5g derived 
ribozyme construct 
in the presence of 
Mg2+ only being 
devoid of kinetic 
traps (U, unfolded; I, 
intermediate, F, folded; 
N, native state). (C) 
Folding pathway in the 
presence of Ca2+. The 
molecules fold into two 
distinct subpopulations 
that do not interchange 
(U, unfolded; I, 
intermediate, F, folded; 
M, misfolded; N, native 
state).
Fig. 4. First NMR solution structure of a metal-modified DNA duplex 
containing three imidazole-Ag+-imidazole base pairs in its center, as 
indicated on the right. The Ag+ ions are shown by red spheres. The Fig. 
has been prepared based on the structure 2KE8[46] using MOLMOL.[23]
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thesis of the metabolite (Fig. 5). Regula-
tion can thereby occur based on structural 
changes, self-cleavage[64] or (alternative) 
splicing.[49,57] Genetic control is mostly 
negative (i.e. switching off gene expres-
sion) but there are also some examples of 
a positive feedback such as the adenine re-
sponding ydhL riboswitch.[65] In addition, 
cooperativity[66] or multiple recognition 
units within so-called tandem riboswitches 
are known.[67,68] 
7.1 Discovery and Structures of B12 
Responsive RNAs
B12 sensing riboswitches are wide-
spread throughout the bacterial kingdom 
and are found in nearly all taxonomic 
groups. They control gene products in-
volved in cobalamin synthesis and trans-
port, cobalt transport, B12-independent 
aerobic and anaerobic ribonucleotide re-
ductase synthesis, as well as glutamate and 
succinate fermentation.[69] 
Kadner and coworkers recorded the 
first structural influence of vitamin B12 (VitB12) and adenosyl cobalamin (coen-
zyme B12, AdoCbl) on a naturally occur-
ring RNA in 1991 with the btuB leading 
sequence of E. coli (Fig. 6A).[70] Subse-
quent investigations with the btuB gene 
and cob operon of S. typhimurium revealed 
a highly conserved 25-nt long sequence 
essential for gene regulation and high-
level expression called the B12-box.[73,74] 
By reverse transcription three highly struc-
tured regions were identified within this 
RNA:[72] i) the ribosome binding site at 
Thy256, ii) Ade202 marking the start of 
the btuB aptamer region, and iii) Cyt161 at 
the beginning of the B12 box. Whereas the 
latter structure is independent of AdoCbl, 
the Ade202 region showed a clear struc-
tural dependence on AdoCbl concentra-
tion. In 2003, a sequence alignment of ap-
proximately 200 B12-aptamers revealed a 
high degree of sequence conservation and 
a first common secondary structure could 
be proposed.[75] This consensus sequence 
included six hairpins arranged around a 
central wheel as well as an antiterminator 
or/and an antisequestor hairpin belonging 
to the expression platform. 
Further investigations revealed two 
types of B12 aptamers: The first includes 
the btuB riboswitches and the longer cob 
operon leading sequence with at least ten 
base-paired regions and around 57 con-
served nucleotides. The second class was 
found in B. subtilis, upstream of the yvrC 
gene lacking the large part around helices 
P8 to P12.[71]
7.2 Gene Regulation by the B12 
Sensing Riboswitches
Depending whether an organism can 
synthesize or has to take up coenzyme B12, 
B12-dependent riboswitches control genes 
involved in the biosynthesis of B12 (e.g. S. 
typhimurium) or uptake and transport of 
the same (e.g. E. coli). For example, the 
cob operon of S. typhimurium encodes 
20 proteins of the cobalamin biosynthetic 
pathway and is controlled by the cob ribo-
switch.[76,77] Instead, the btuB riboswitch 
regulates a single gene encoding for an 
outer membrane transporter responsible 
for the active transport of cobalamins into 
the periplasmic space.[78–80] Both ribo-
switches are negatively controlled on both 
the transcriptional and the translational 
level and the structural rearrangements 
seem to correlate well.[70,81] In the btuB 
riboswitch, the first 240 nucleotides are 
responsible for the translational control 
of gene expression by sequestration of the 
Shine-Dalgarno sequence, the binding site 
of the 16S rRNA unit of the ribosome (Fig. 
6A). Instead, the first 100 nucleotides of 
the coding sequence are compulsory for 
a Rho-independent transcriptional regu-
lation (Fig. 6).[73] A possible mechanism 
of gene regulation is the formation of a 
pseudo-knot upon binding to AdoCbl and 
the resulting reorganization of the expres-
sion platform. However in-line probing ex-
periments demonstrated also a substantial 
structural rearrangement of the aptamer 
region upon binding to AdoCbl and some 
of its derivatives (Fig. 7).[53] 
7.3 Specific Recognition of AdoCbl 
by the btuB Riboswitch
The organometallic complex coen-
zyme B12 is the largest and most complex 
of all coenzymes (Fig. 6B). AdoCbl and its 
Fig. 5. General mechanism of a riboswitch. Binding of the metabolite to its aptamer region of 
the riboswitch leads to a structural rearrangement of this domain as well as of the expression 
platform and subsequently to an altered gene expression. Such metabolites are amino acids 
(lysine and glycine), purine bases (adenine, guanine and prequenosine-1), cofactors (AdoCbl, 
flavin mononucleotide, S-adenosyl methionine, tetrahydrofolate, thiamine pyrophosphate, 
molybdenum and tungsten cofactors), metal ions (Mg2+), small nucleotide-units acting as second 
messenger (c-di-GMP) or others (glucosamine-6-phosphate, S-adenosyl homocysteine).[49]
Fig. 6. The btuB riboswitch and its metabolite coenzyme B12. (A) Secondary structure of the 
btuB riboswitch from E. coli in the presence of AdoCbl. The aptamer region of the riboswitch 
covers nucleotide 1 to 202 and includes a pseudoknot (magenta) and the B12-box (pink).
[71] The 
expression platform is situated between nucleotides 209 and 288 and contains a translational 
regulatory element (the ribosomal binding site(RBS)-sequestor hairpin with the Shine-Dalgarno 
sequence in light green)[72] and a transcriptional regulatory element (termination stem) being part 
of the coding sequence (orange).[73] (B) General formula of B12 molecules with an axial dimethyl 
benzimidazole ligand as present in AdoCbl, VitB12, and their acid derivatives. (C) Intramolecular 
equilibrium between the ‘base-on’ and ‘base-off’ forms of the B12 derivatives. Under physiological 
conditions, AdoCbl is found exclusively in the ‘base-on’ form, whereas in the case of adenosyl 
factor A the ‘base-off’ form prevails.
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derivatives are considered the evolutionary 
most ancient protein cofactors[82–84] and 
might have already played a role in the 
so-called RNA world.[85] This ancient re-
lationship between a nucleic acid and this 
fascinating metal ion complex triggered 
our interest already some time ago. 
The first example of a RNA that binds 
specifically to a B12 derivative was discov-
ered in 1994 by Szostak and coworkers in 
in vitro selection experiments.[86] This syn-
thetic aptamer of 35 nucleotides in length 
selectively binds VitB12 (KD = 90 nM) over 
other B12 derivatives such as dicyanoco-
binamide (20 mM) or the larger AdoCbl, 
which does not bind. The X-ray crystal 
structure[87] revealed that a large hydro-
phobic pocket is situated at the interface 
between a small duplex and a unique triple 
helix structure. Selective VitB12 binding is 
achieved by a dense network of different 
interactions including hydrophobic and 
electrostatic interactions, hydrogen-bond-
ing as well as the insertion of the cyanide 
ligand of VitB12 into the base-triplet of the 
triple helix, the latter explaining the selec-
tivity for cyanide-carrying B12 molecules. 
As numerous B12 derivatives occur in 
nature, a different selection scheme is ex-
pected for natural B12 aptamers. Indeed, 
the two best studied B12 riboswitches, the 
btuB riboswitch and the leading sequence 
of the cob operon, show a high selectiv-
ity for AdoCbl (the most abundant form 
of B12, KD = 89 ± 6 nM with btuB) over 
VitB12 (KD = 314 ± 141 mM ).[50,53,81] Our 
investigations concentrate currently on the 
structural basis for the interaction between 
AdoCbl and the 202 nt long aptamer re-
gion of the btuB riboswitch of E. coli.[51] In 
contrast to VitB12, AdoCbl is able to release 
the lower dimethylbenzimidazol ligand in 
an intramolecular equilibrium, i.e. lead-
ing to a ‘base-off’ form (Fig. 6C). From 
protein interactions it is known that either 
the ‘base-on’ or the ‘base-off’ form can be 
bound.
In order to elucidate the binding mode 
to the riboswitch, we applied various struc-
turally different B12 derivatives, i.e. miss-
ing either the upper (VitB12), the lower (ad-
enosyl cobinamide) or both large apical li-
gands (dicyanocobinamide), or displaying 
the ‘base-off’-form (adenosyl factor A).[51] 
The conformational changes of the RNA 
upon interaction with the different B12 de-
rivatives was visualized by in-line probing 
experiments, i.e. structure-dependent self-
degradation of RNA (Fig. 7). The confor-
mational switch of the RNA was followed 
by the appearance or disappearance of 
nine distinct cleavage bands upon binding 
to AdoCbl (Fig. 7).[51,53] The nine cleavage 
sites are spread over the whole sequence, 
implying that binding to AdoCbl leads to 
an overall structural rearrangement of the 
RNA.
In contrast to earlier studies,[53,71,72] our 
experiments showed the adenosyl-moiety 
on the upper side of the corrin ring not to 
be compulsory for the switching of the 
RNA.[51] If present in high concentrations, 
also VitB12 induces a correct switch of the 
btuB RNA (Fig. 7). Similarly, the pres-
ence and conformation of the lower part of 
the B12 derivative is of minor importance. 
Adenosyl cobinamide as well as the steri-
cally more demanding adenosyl factor A 
(AdoFactA) allow essentially the same re-
arrangement of the riboswitch as AdoCbl. 
The unexpected high affinity for AdoFactA 
(KD = 290 ± 32 nM) further suggests that 
the ‘base-off’ nature of this ligand does not 
disturb the interaction with the RNA. UV 
studies showed further that the lower base 
is not replaced by a RNA nucleotide at the 
cobalt coordination site.[51] As a direct con-
sequence of the indicated results, one can 
conclude that the presence of the two axial 
ligands increase the B12-RNA interaction 
each by a factor of almost 1000.[51] 
In contrast, the corrin ring with its side 
chains is directly responsible for the struc-
tural switch of the btuB RNA. We investi-
gated the role of single amide side chains 
on riboswitch restructuration by applying 
B12 derivatives such as the b-, c-, d- and 
e-acid derivatives of VitB12 (Fig. 6B) in 
in-line probing experiments. Application 
of these derivatives, all having one single 
amide group replaced by a carboxylic 
acid, provides a first insight in the impor-
tance of the correct H-bonding pattern and 
electrostatic environment on btuB RNA 
switching.[50] Interestingly, most B12-acid 
derivatives only lead to a partial rearrange-
ment, whereas binding of the c-acid B12 is 
followed by a completely altered structural 
change. These findings corroborate the hy-
pothesis that the amide side chains of the 
corrin ring are of uttermost importance for 
btuB RNA switching.
8. Conclusions and Outlook
The specific coordination of metal ions 
and metal ion complexes to nucleic acids is 
highly complex and goes in most instances 
far beyond a simple coulombic interac-
tion. Relatively fast ligand exchange rates, 
rather low affinities, and the mostly spec-
troscopically silent metal ions involved, 
make the characterization of this interplay 
highly challenging.[5,8] The combination of 
inner-sphere metal ion coordination with 
an extensive hydrogen bonding network 
via coordinated water molecules allows 
on the one hand a rather tight binding in 
preformed pockets, but on the other hand 
also a high degree of flexibility and dy-
namics. The dynamics of metal ion bind-
ing seem to play a crucial role for ribo-
zyme activity, e.g. single group II intron 
molecules become more dynamic in their 
domain movements with increasing Mg2+ 
concentration.[42] 
Our efforts aim to elucidate the basic 
principles of metal ion binding and to char-
acterize the effect thereof on global struc-
ture, dynamics, and catalytic mechanism. 
Fig. 7. In-line probing experiments with the btuB riboswitch in the 
presence of different B12 derivatives. Addition of AdoCbl (top) leads 
to the decrease of the intensity of bands 3 and 2b while cleavage 
increases at site 2. VitB12 (middle) shows the same pattern but only 
at higher concentrations. c-acid VitB12 (bottom) binds, but prevents 
the riboswitch from a correct rearrangement, as is obvious from the 
different cleavage pattern of the RNA. B12 concentrations range from 
30 nM to 0.1 mM (AdoCbl), 3.3 mM to 10 mM (VitB12), and 1 mM to 0.75 
mM (c-acid VitB12).
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The importance of the knowledge of, e.g. 
the intrinsic binding affinities is exemplified 
by the recent discovery that the catalytic 
rate of the hammerhead ribozyme is directly 
dependent on the phosphate affinity of the 
divalent metal ion present.[8] Such relatively 
‘simple’ correlations might turn out to be 
also true for other small ribozymes. In the 
case of the large ribozymes, more compli-
cated interdependencies between metal ions 
and the RNA are to be expected because of 
the above-mentioned reasons.
To conclude, a highly interdisciplin-
ary approach will be needed to understand 
the diverse world of ribozymes and ribo-
switch structures and functions depending 
on metal ions and/or metal ion complexes. 
At the same time we may expect surprising 
and unprecedented turns and twists in this 
fascinating field of Biological Inorganic 
Chemistry.
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